Related Experiment Video

Updated: Aug 30, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

[Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention]

Kalina Kawecka-Jaszcz1, Andrzej Pajak, Piotr Jankowski

  • 1I Klinika Kardiologii Instytutu Kardiologii Collegium Medicum Uniwersytetu Jagiellońskiegio w Krakowie, 31-501 Kraków, ul. Kopernika 17. piotrjankowski@interia.pl

Przeglad Lekarski
|October 25, 2003
PubMed

Insights

The Cracovian Program assessed secondary prevention of ischaemic heart disease in Poland. Interventions improved physician and patient adherence to guidelines, but further improvements are needed.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Secondary prevention of ischaemic heart disease (IHD) is crucial for patient outcomes.
  • The Cracovian Program is Poland's first comprehensive initiative to assess and improve IHD secondary prevention.
  • Initial assessment revealed suboptimal implementation of IHD guidelines.

Purpose of the Study:

  • To evaluate the quality of secondary prevention of ischaemic heart disease in Poland.
  • To implement interventions aimed at improving physician and patient adherence to IHD guidelines.
  • To reassess the implementation of IHD secondary prevention recommendations after interventions.

Main Methods:

  • The study involved two stages (1997-1998 and 1999-2000) assessing IHD secondary prevention.
  • Interventions included physician training and patient education leaflets.
  • Data analysis focused on the implementation of IHD guidelines during hospitalization and post-discharge.

Main Results:

  • The first stage indicated poor adherence to IHD secondary prevention recommendations.
  • Interventions were implemented to address identified gaps in care.
  • The second stage reassessed the impact of these interventions on guideline implementation.

Conclusions:

  • The Cracovian Program highlighted significant gaps in the implementation of ischaemic heart disease secondary prevention guidelines.
  • Interventions aimed at healthcare providers and patients were introduced to improve adherence.
  • Further evaluation is needed to assess the long-term impact on patient outcomes and guideline adherence.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...